QuidelOrtho Corporation Common Stock QDEL
HEALTHCARE · MEDICAL DEVICESi
Market dataready · fetched 2026-11-12T03:21:10.749Z
Delta surfaceAlpaca · derived absolute-delta buckets · 2026-11-20
Calculation methodologyOptions historyIV: ThetaData historical Greeks, equal-weight mean of call/put 50-delta IV across the next four listed Friday-cycle expirations, including holiday shifts verified against ThetaData’s market calendar. Missing inputs leave gaps. Skew: equal-weight mean of put minus call IV across those four expirations. IV-implied move history: mean of each expiration’s average call/put IV multiplied by the square root of remaining calendar days divided by 365.25; percentage of spot, not a quoted straddle premium.
History dataPriceAlpaca · sip · 2026-11-11T21:00:01.175699093Z
FundamentalsAlpha Vantage · ready · quarter 2026-09-30 · fetched 2026-11-12T03:21:10.378365+00:00
QuidelOrtho Corporation Common Stock options
Table
| Delta | Calls | Puts | ||||
|---|---|---|---|---|---|---|
| Pseudo strike | IV | B/E move | Pseudo strike | IV | B/E move | |
| 20Δ | ||||||
| 25Δ | 10.34 | 164.5% | 17.8% | |||
| 30Δ | 10.74 | 164.6% | 16.0% | |||
| 35Δ | 11.13 | 164.8% | 14.3% | |||
| 40Δ | 13.38 | 148.4% | 18.1% | 11.53 | 164.9% | 12.5% |
| 45Δ | 12.57 | 137.2% | 12.0% | 11.92 | 165.0% | 10.7% |
| 50Δ | 12.19 | 136.5% | 10.3% | 12.32 | 165.2% | 8.9% |
| 55Δ | 11.85 | 136.8% | 9.1% | 12.68 | 161.2% | 7.5% |
| 60Δ | 11.51 | 137.1% | 7.9% | 13.02 | 153.8% | 6.5% |
| 65Δ | 11.16 | 137.4% | 6.6% | 13.36 | 146.4% | 5.5% |
| 70Δ | 10.82 | 137.8% | 5.4% | 13.70 | 138.9% | 4.5% |
| 75Δ | 10.48 | 138.1% | 4.2% | 14.04 | 131.5% | 3.5% |
| 80Δ | 10.14 | 138.4% | 2.9% | |||
20Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- IV
- B/E move
25Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- 10.34
- IV
- 164.5%
- B/E move
- 17.8%
30Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- 10.74
- IV
- 164.6%
- B/E move
- 16.0%
35Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- 11.13
- IV
- 164.8%
- B/E move
- 14.3%
40Δ
- Pseudo strike
- 13.38
- IV
- 148.4%
- B/E move
- 18.1%
- Pseudo strike
- 11.53
- IV
- 164.9%
- B/E move
- 12.5%
45Δ
- Pseudo strike
- 12.57
- IV
- 137.2%
- B/E move
- 12.0%
- Pseudo strike
- 11.92
- IV
- 165.0%
- B/E move
- 10.7%
50Δ
- Pseudo strike
- 12.19
- IV
- 136.5%
- B/E move
- 10.3%
- Pseudo strike
- 12.32
- IV
- 165.2%
- B/E move
- 8.9%
55Δ
- Pseudo strike
- 11.85
- IV
- 136.8%
- B/E move
- 9.1%
- Pseudo strike
- 12.68
- IV
- 161.2%
- B/E move
- 7.5%
60Δ
- Pseudo strike
- 11.51
- IV
- 137.1%
- B/E move
- 7.9%
- Pseudo strike
- 13.02
- IV
- 153.8%
- B/E move
- 6.5%
65Δ
- Pseudo strike
- 11.16
- IV
- 137.4%
- B/E move
- 6.6%
- Pseudo strike
- 13.36
- IV
- 146.4%
- B/E move
- 5.5%
70Δ
- Pseudo strike
- 10.82
- IV
- 137.8%
- B/E move
- 5.4%
- Pseudo strike
- 13.70
- IV
- 138.9%
- B/E move
- 4.5%
75Δ
- Pseudo strike
- 10.48
- IV
- 138.1%
- B/E move
- 4.2%
- Pseudo strike
- 14.04
- IV
- 131.5%
- B/E move
- 3.5%
80Δ
- Pseudo strike
- 10.14
- IV
- 138.4%
- B/E move
- 2.9%
- Pseudo strike
- IV
- B/E move
Options history
Table
| Date | IV (%) |
|---|---|
| 94.92% | |
| 93.28% | |
| 88.62% | |
| 92.83% | |
| 97.96% | |
| 105.81% | |
| 87.71% | |
| 94.02% | |
| 92.46% | |
| 102.95% |
Medical Devices
QSI
Quantum-Si incorporated operates the first next-generation protein sequencing platform for the healthcare industries.
More →QTRX
Quanterix Corporation, a life sciences company, develops and markets digital immunoassay platforms that advance precision health for life sciences research and diagnostics in…
More →RCEL
AVITA Medical Inc. is a commercial stage regenerative tissue company in the United States, Australia, and the United Kingdom. The company is headquartered in Valencia, California.
More →RXST
Rxsight Inc. is a cutting-edge healthcare technology company dedicated to transforming vision correction through advanced diagnostic and surgical solutions in refractive eye…
More →SENS
Senseonics Holdings, Inc., a medical technology company, develops and markets continuous glucose monitoring (CGM) systems for people with diabetes in the United States, Europe,…
More →SGHT
Sight Sciences Inc. (SGHT) is an innovative medical technology company specializing in the advancement of treatments for ocular diseases, with a particular emphasis on glaucoma…
More →